A deletion mntation in the factor VIII gene of a severe haemophiliac patient was found along with a high level of factor VIII inhibitor in the blood plasma among seventy Japanese haemophilia A patients. The 6 kbp long deletion involved a region from somewhere between PstI and SstI sites at nucleotide positions 2659 and 2991 of exon 14 and intron 13, respectively (nucleotide positions were defined as in Wood et al., 1984) .
INTRODUCTION
Haemophilia A (classical haemophilia) is one of the most abundunt inherited bleeding disorders caused by genetic deficiency of the coagulation protein, factor VIII. The clinical severity in patients with haemophilia varies mainly due to different levels of factor VIII activity among different families. Moreover, about 10~ of patients with severe haemophilia have high levels of antibodies against factor VIII, so-called factor VIII inhibitor. The genetic heterogeneity of haemophilia patients suggests that many different molecular alterations are involved in the resultant malfunctional factor VIII gene in haemophiliacs. Several point and deletion mutations in the factor VIII gene were observed in Caucasian population (Gitschier et al., 1985 (Gitschier et al., , 1986 Antonarakis et al., 1985; Youssoufian et al., 1986 Youssoufian et al., , 1987a Youssoufian et al., , 1987b Higuchi et al., 1987; Bernardi et aL, 1987; Matthews et al., 1987) .
We report of an example of deletion extending from intron 13 to exon 14 of factor VIII gene in a Japanese patient with haemophilia A and high level of inhibitor.
CASE REPORT
The patient (24 years of age, male) showed a severe haemophilia A, having less than 1~ of factor VIII coagulant activity assayed by one stage method (Hardisty and Macpherson, 1962) and less than 0.1 ~ of factor VIII coagulant antigen assayed by IRMA (Peake et al., 1979) . His typical bleeding episodes were the repeated intracranial bleedings. At the age of 17 years, inhibitor against factor VIII developed, and the maximal titers were 74 Bethesda units/ml. He has no siblings but a normal son. His mother was diagnosed previously to be a carrier (30~ factor VIII coagulant activity).
METHODS
Chromosomal DNA was isolated from leukocytes and digested with TaqI, EcoRI, BamHI, KpnI and SstI restriction endonucleases. Gel electrophoresis, radioisotope labeling and Southern blotting were performed as previously described (Maniatis et aI., 1982) . DNA probes used for Southern analysis are shown in Fig.  1 . Briefly, (1) probe A, 1.7 kbp long, delineates exons 1-12, (2) probe B, 4.7 kbp long, delineates exons 14-26, (3) probe C, 1.8 kbp, contains the remaining portion of exon 26, (4) probe D, 0.37 kpb, contains the portion of exon 14 between EcoRI and PstI sites at positions 2290 and 2658, respectively, (5) probe E, 2.5 kbp, contains another portion of exon 14 between two PstI sites at positions 2659 and 5163. The probes A, B and C are contained in pSP64, Ap g (Antonarakis et al., 1985) , kindly provided by Dr. Lewis, Genetics Institute, whilst probes D and E are contained in pHSG398, Cm ~ (Takeshita et al., 1987) .
RESULTS
Autoradiographs of Southern blots of normal and patient genomic DNA samples are shown in Fig. 2 . The DNA samples digested with TaqI were hybridized to probe A, and those digested with TaqI, EcoRI, BamHI or KpnI, were hybridized to probes B and C. Probe A detected several fragments of 8.0 kbp (exons 3-4), 4.3 kbp (exon 7), 2.4 kbp (exon 11), 2.2 kbp (exon 1), 1.8 kbp (exons 7-9) and 1.4 kbp (exon 2) in length. The size of these fragments were all normal (data not shown).
The use of probes B and C revealed fragments of different size in patient DNA when digested with Taqi, EcoRI, BarnHI and KpnI. In normal subject, TaqI digestion showed 9.2 kbp (exon 26), 5.9 kbp (exon 14 and exons 20-22), 2.8 kbp (exons 15-18, exons 2425 and exon 26), 2.4 kbp (exon 23), 2.2 kbp (exons 18-19) and 1.4 kbp (exons 23-24) fragments (Gitschier et al., 1985) . In patient, the major 5.9 kbp fragment that corresponds to exon 14, was replaced by a smaller fragment of 4.9 kbp. In EcoRI digestion of patient DNA, the major fragment of 4.8 kbp (exon 14) Probes D and E. Probe B inserted in pSP64 was restricted with either EcoRI § PstI or PstI. Subfragments inserted into pHSG398, were cultured and screened. Probes D and E were obtained by gel electrophoresis.
was undetectable. BamHI digestion showed a new fragment and a normal-sized 0.6 kbp fragment of exon 14. KpnI digestion also showed a new fragment. Probe D detected no band in patient DNA by BamHI digestion, and probe E detected a new fragment of 5.9 kbp by EcoRI digestion in addition to the 3.2 kbp fragment by SstI digestion (Fig. 3) . Disappearance of the 4.8 kbp major fragment of exon I4, when digested with EcoRI and hybridized with probes B and C, was caused by an overup of the 5.9 kbp abnormal fragment derived from exon 14 and 5.9 kbp fragment from exon 26.
From these results, patient factor VIII gene has a partial deletion of approximately 6 kbp to 5' side from a site between PstI site (2659) and Sst[ site (2991) exon 14, according to the restriction map of factor VIII gene (Gitschier et aI., 1984; Wood et al., 1984) .
DISCUSSION
It was clear by the use of cDNA probes for factor VIII DNA that a severe Japanese haemophilia A patient with high titers of inhibitor has a intragenic deletion of factor VIII gene. From Southern blot analysis and the restriction map of factor VIII gene (Gitschier et al., , 1985 Wood et al., 1984) , gene deletion in the patient DNA includes a part of exon 14, accounting for approximately 6 kbp in length.
So far, more than 10 cases of gene deletion have been reported in Caucasian haemophilia A patients (Table 1) . As far as the gene deletion of exon 14 is concerned, a small deletion of 2.5 kbp or 2.0-2.5 kbp was not involved in the occurrence of an antibody (inhibitor) against factor VIII (Youssoufian et al., 1987a; Higuchi et al., 1987) . However, a large deletion of 12-14 kbp containing exon 14 caused inhibitor (Higuchi et al., 1987) . On the other hand, it was reported that several nonsense mutations in exons of factor VIII gene resulted in the development of inhibitor (Gitschier et al., 1985; Higuchi et al., 1987; Matthews et aI., 1987; Mikami et al., 1988) . Therefore, it will be important to characterize the association between gene defects and epitope specificity of inhibitor against factor VIII.
Factor VIII gene has 186 kbp in length including 26 exons and exon 14 encodes a large part of factor VIII amino acid sequence, called B domain (Gitschier et aI., 1984) , including thrombin cleavage sites in both ends. This domain connects A s and A3 domains that play important roles for factor VIII coagulant activity (Vehar Jpn. or. Human Genet. 
II 1
Deletion "] 6Kbp
Southern blots by exon 14 probes (probes D and E) and a local restriction map of factor VIII gene.
et al., 1984) . Toole et al. (1986) demonstrated that factor VIII c D N A s deficient in B domain polypeptide, when inserted into m a m m a l i a n cell expression vector, directed the synthesis of biologically active factor VIII. The patient, whose D N A had deletion in the region of exon 14, shows neither factor V I I I coagulant activity nor autologous antigen specificity. In summary, we examined 64 Japanese haemophilia A patients and 6 cases with inhibitor. A m o n g these, one case of gene deletion was detected. Table 1 . Gene deletion of factor VIII in haemophiliac patients. All cases except for a mild form (*) reported are severe form.
